Cost-effectiveness findings not based on available evidence.
Fenn
Chris G
CG
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects / Q000191:economics* / Q000627:therapeutic use; D003362:Cost-Benefit Analysis; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects / Q000191:economics*; D016527:Drug Costs; D004345:Drug Industry; D019317:Evidence-Based Medicine; D006801:Humans; D012680:Sensitivity and Specificity; D014481:United States; D014486:United States Food and Drug Administration
D000894:Anti-Inflammatory Agents, Non-Steroidal; D016861:Cyclooxygenase Inhibitors